# Knee replacement alternatives: what to consider first *Knee replacement alternatives - non-surgical knee treatment Gilbert* > Knee replacement alternatives and non-surgical knee treatment Gilbert choices, explained by purpose, visit, and daily needs. The Loop 202 takes SanTan Village drivers toward Chandler. The drive is simple; a knee surgery decision isn't. The exam, daily limits, earlier care, and general health all matter. ## What knee replacement alternatives can do Alternatives to knee replacement surgery may ease soreness or delay an operation. They don't make a worn knee new, but exercise, useful weight loss, braces, canes, gel, and medicine may help. Physical therapy can build strength and make movement safer. Choose care by the daily task you need to regain. Surgery may make sense when soreness and lost movement control most days, though its risks come with a long recovery. Ask what waiting may cost and what surgery may improve. This is a medical choice, not a test of toughness. ## What to ask about blood-based treatment choices After a knee exam, QC Kinetix may discuss PRP or concentrated PRP. Both start with some of your blood. A machine separates the sample so staff can keep liquid containing more platelets, the cells used in clotting. A medical provider puts that liquid in the sore knee. The clinic calls these choices regenerative treatments, biologic therapies, natural pain treatments, or orthobiologics. Joint preservation means considering this care before knee replacement. A clinic term doesn't explain what will happen to the knee. Ask who performs the treatment and what happens afterward. Find out when staff will recheck walking, sleep, or swelling. The discussion should cover other care and the chance that surgery may still be needed. No clinic can promise that PRP will help. ## How to decide whether surgery can wait Watch the knee over several ordinary days before deciding. Note walking distance, sleep, stairs, swelling, and any giving way. Record which treatments helped and how long the relief lasted. The clinician can compare those details with the exam and X-ray. Waiting isn't always safer, and surgery isn't always the next choice. Ask the surgeon and non-surgical clinician the same things. Ask about likely relief, risks, and recovery. Also ask what may happen if care stays the same. Compare the answers without rushing. You make the decision after both clinicians explain their reasons. ## Sources 1. In the only randomised controlled trial to compare total knee replacement directly with non-surgical treatment in patients already eligible for surgery (n=100), the replacement group improved more at 12 months than the non-surgical group (KOOS4 32.5 vs 16.0; adjusted mean difference 15.8, 95% CI 10.0 to 21.5) but had four times the serious adverse events (24 vs 6, P=0.005). Only 13 of 50 patients (26%) assigned to non-surgical treatment alone had undergone knee replacement by 12 months. Skou ST, Roos EM, Laursen MB, et al. — [A Randomized, Controlled Trial of Total Knee Replacement.](https://pubmed.ncbi.nlm.nih.gov/26488691/). *New England Journal of Medicine*, 2015. DOI: 10.1056/NEJMoa1505467. 2. The RESTORE trial randomised 288 community-based participants aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence grade 2 or 3) to three weekly intra-articular injections of leukocyte-poor PRP or saline placebo, with participants, injectors and assessors all blinded. 93% completed the 12-month follow-up. PRP did not produce a clinically meaningful improvement in knee pain over placebo, and did not slow medial tibial cartilage volume loss on MRI. Bennell KL, Paterson KL, Metcalf BR, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 3. A meta-analysis of 16 randomised trials (807 participants) of intra-articular mesenchymal stem cells for chronic knee pain from osteoarthritis found that at 3-6 months MSC therapy probably produces little to no difference in pain (WMD -0.74cm on a 10cm VAS, 95% CI -1.16 to -0.33, against a minimally important difference of 1.5cm) or physical function, both moderate certainty; at 12 months, probably little to no difference in pain. MSC therapy may increase the risk of any adverse event (RR 2.67, 95% CI 1.19 to 5.99) and of knee pain and swelling (RR 1.58, 95% CI 1.04 to 2.38). Sadeghirad B, Rehman Y, Khosravirad A, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and Cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. 4. FDA states directly that regenerative medicine therapies - including stem cells, stromal vascular fraction, umbilical cord blood, amniotic fluid, Wharton's jelly, ortho-biologics and exosomes - have NOT been approved for the treatment of any orthopedic condition, naming osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain. FDA further states that being charged for these products, or being offered them outside an FDA-overseen clinical trial, means a patient is likely being deceived and offered a product illegally, and that a product's presence on clinicaltrials.gov or a firm's FDA registration does not mean the product is legally marketed. Reported harms include blindness, tumor formation, neurological events and life-threatening bacterial infections. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Important Patient and Consumer Information About Regenerative Medicine Therapies](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies). *FDA.gov*, 2021. 5. A 2026 Cochrane review searching from 2010 to January 2025 found only ONE randomised trial (100 participants, Denmark) comparing knee arthroplasty with non-surgical treatment. Low-certainty evidence indicated TKA may reduce pain at one year by a clinically important margin (MD 17.60, 95% CI 8.25 to 26.95) and may improve function by an amount that might not be clinically important (MD 12.40), with probably no clinically important difference in health-related quality of life. Cochrane Musculoskeletal Group — [Total and partial knee arthroplasty versus non-surgical interventions of the knee for moderate to severe osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/41494148/). *Cochrane Database of Systematic Reviews*, 2026. DOI: 10.1002/14651858.CD015378.pub2. ## When an exam would help An exam can help when the knee stays sore or limits normal errands. Take any X-rays and a current medicine list. Note the soreness start date and which activities ease or worsen it. QC Kinetix (Chandler) is the nearest location to Gilbert. Its clinic staff examine knees and discuss non-surgical options. They can explain how they use your blood to prepare PRP or concentrated PRP. You won't have to choose a treatment before the exam. Schedule a free consultation: --- Straight answers for knee soreness. Plain guidance on a sore knee, care at home, clinic visits, surgery choices, and blood-based treatments near Gilbert. Plain guidance for Gilbert readers who want to understand knee soreness and their non-surgical choices. This site is operated by the owners of the QC Kinetix clinics serving the Phoenix area, including the Chandler office named throughout these pages as the nearest location to Gilbert. Read it as first-party writing from a business that benefits when you call, which is exactly why every figure here is tied to a study you can open and read against us. 2026 The Gilbert Knee Ladder, Gilbert, Arizona. General education about knee care, not medical advice about your knee or a substitute for assessment by a clinician.